EUVIMEDEUVIMED entdecken
Crossref

Cell-Targeted Nanocomplex Facilitates Direct Reprogramming of Astrocytes into Dopaminergic Neurons in Parkinson’s Disease

Yerim Hwang, Neethu Ramakrishnan, Junyeop Kim, Sumin Kim, Jeonghyun Park, Daeyeol Kwon, Saemin An, Youngeun Kwon, Jongpil Kim

Acta Biomaterialia · 2026-04 · 214 · 483-497

DOI: 10.1016/j.actbio.2026.02.055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-04. Verfasst von Yerim Hwang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic ad…. Hauptthemen laut MEDLINE: Astrocytes, Dopaminergic Neurons, Metal Nanoparticles, Parkinson Disease. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct in vivo reprogramming of dopaminergic neurons represents a transformative approach for neuroregeneration, enabling the generation of new functional dopamine neurons in the brain and offering direct therapeutic potential for Parkinson's disease. However, the complex milieu of the adult brain, where persistent barriers to cellular specificity remain, continues to challenge the efficiency and success of conversion into induced dopaminergic (iDA) neurons. To overcome these limitations, we developed astrocyte-targeted system for conversion into iDA neurons using functionalized gold nanoparticle-based nanocomplexes with cell-specific ligands for targeted transdifferentiation. This system facilitated robust astrocyte-to-dopaminergic neuron conversion both in vitro and in vivo, with strong expression of dopaminergic markers exclusively in targeted astrocytes. Moreover, this astrocyte-targeted nanocomplex promoted the activation of successful reprogramming pathways, further enhancing reprogramming efficacy. Application of this cell-targeted nanocomplex system in a 6-OHDA-induced Parkinson's disease mouse model resulted in substantial increases in newly generated dopaminergic neurons, restoration of striatal dopamine levels, and significant improvements in multiple motor functions. These findings establish a cell-targeted, functionalized nanocomplex capable of highly selective in vivo reprogramming, offering a promising and targeted therapeutic strategy for Parkinson's disease. STATEMENT OF SIGNIFICANCE: Direct reprogramming of glial cells into dopaminergic neurons represents a promising therapeutic strategy for Parkinson's disease, although achieving selective and efficient conversion in the adult brain remains challenging. Here, we report astrocyte-targeted induced dopaminergic neurons reprogramming in vivo using functionalized gold nanoparticle nanocomplexes. This platform enables efficient conversion of astrocytes into functional dopaminergic neurons, leading to restored dopamine levels and improved motor function in a Parkinson's disease mouse model. Unlike non-targeted approaches, our system achieves high targeting precision and successful direct cellular conversion. Collectively, these results demonstrate that precision-engineered, cell-selective biomaterials can effectively guide cell fate in the brain, representing a significant step toward safe and targeted regenerative therapies through direct reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesDopaminergic NeuronsMetal NanoparticlesParkinson DiseaseCellular ReprogrammingAnimalsGoldMiceMice, Inbred C57BLMaleOxidopamine

Stichwörter der Autor:innen

Cell-targeted gene deliveryDirect lineage reprogrammingGold nanoparticle nanocomplexInduced dopaminergic neuronsParkinson’s disease

Substanzen

GoldOxidopamine

Autor:innen und Institutionen

  • Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic address: yrhwang31@gmail.com.
  • Department of Biomedical Engineering, Dongguk University, 10326, Ilsan, Republic of Korea. Electronic address: neethuramakrishnan957@gmail.com.
  • Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic address: jkim8992@gmail.com.
  • Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic address: z01096535653@naver.com.
  • Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic address: junghyun2017@gmail.com.
  • Institute for Stem Cells and Regenerative Medicine (ISR), Department of Chemistry, Dongguk University, Seoul, 10326, Republic of Korea. Electronic address: chemdaeyeol@gmail.com.

Zitieren

APA

Hwang, Y., Ramakrishnan, N., Kim, J., Kim, S., Park, J., Kwon, D., An, S., Kwon, Y., & Kim, J. (2026). Cell-Targeted Nanocomplex Facilitates Direct Reprogramming of Astrocytes into Dopaminergic Neurons in Parkinson’s Disease. Acta Biomaterialia, 214, 483-497. https://doi.org/10.1016/j.actbio.2026.02.055

Vancouver

Hwang Y, Ramakrishnan N, Kim J, Kim S, Park J, Kwon D, et al. Cell-Targeted Nanocomplex Facilitates Direct Reprogramming of Astrocytes into Dopaminergic Neurons in Parkinson’s Disease. Acta Biomaterialia. 2026;214:483-497. doi:10.1016/j.actbio.2026.02.055

BibTeX
@article{Hwang2026,
  author = {Hwang, Yerim and Ramakrishnan, Neethu and Kim, Junyeop and Kim, Sumin and Park, Jeonghyun and Kwon, Daeyeol and An, Saemin and Kwon, Youngeun and Kim, Jongpil},
  title = {Cell-Targeted Nanocomplex Facilitates Direct Reprogramming of Astrocytes into Dopaminergic Neurons in Parkinson’s Disease},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {214},
  pages = {483--497},
  doi = {10.1016/j.actbio.2026.02.055}
}
Kostenlos starten →